NCT05396027

Brief Summary

Diaphragmatic breathing brings different advantages to improve physical and mental health but it could be difficult for the physically disabled group to follow the practice by themselves especially those with vision impairment. Therefore, guided deep breathing is desirable to address their needs but these are rarely analyzed in the previous literature. This research aims to study the physiological impacts and psychological health of audio-guided deep breathing on physically disabled groups. The psychological changes will be assessed by Perceived Stress Scale (PSS), World Health Organization Quality of Life (WHO-BREF) and Cognitive and Affective Mindfulness Scale-Revised (CAMS-R). Besides, physiological parameters such as tidal volume, electroencephalography, hair cortisol level and heart rate variability are measured non-invasively to evaluate the impact of audio-guided deep breathing. Furthermore, auditory Go-No Go Task will be adopted as a neuropsychological test in determining changes in response control and sustained attention in this study as well. Eventually, the pre-and post-interventional data will be analyzed and processed to study the effect of audio-guided deep breathing on these special groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 27, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

June 6, 2022

Status Verified

June 1, 2022

Enrollment Period

1 year

First QC Date

May 24, 2022

Last Update Submit

June 1, 2022

Conditions

Keywords

Guided Deep BreathingVisual ImpairmentPhysical DisabilityMental Stress

Outcome Measures

Primary Outcomes (10)

  • Change from baseline stress by Perceived Stress Scale (PSS)

    PSS is an international instrument that is designed to evaluate the individual's stress level. It requires participants to rate their feeling and thoughts in the past month in the different cases provided. The rating is described as a scale of 0 (never) to 4 (very often). If the summated score is high, it is always associated with a higher level of perceived stress.

    Baseline, 14 days

  • Change from baseline quality of life by World Health Organization Quality of Life - BREF (WHO-BREF)

    WHO-BREF consists of 26 items that are divided into four domains namely physical health, psychological, social relationships and environment to measure participants' quality of life. The scores follow five-point Likert Scales where 1 represents "disagree" or "not at all" and 5 represents "completely agree" or "extremely". Higher scores indicate higher quality of life.

    Baseline, 14 days

  • Change from baseline mindfulness level by Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)

    CAMS-R is a ten-item scales designed to measure one's mindfulness approach to relate their feeling, emotion and thought. It is presented in four Likert scales from 1 (Rarely/Not at all) to 4 (Almost always) which require the participant to rate how applicable each item is to them.

    Baseline, 14 days

  • Change from baseline Alpha waves by Non-invasive electroencephalogram (EEG)

    The 32- channel electrodes were placed in compliance with the International 10-20 System nomenclature. The increase or decrease in Alpha wave EEG recordings of the participants are recorded in eyes closed for 1 min

    Baseline, 7 days, 14 days

  • Change from baseline Beta waves by Non-invasive electroencephalogram (EEG)

    The 32- channel electrodes were placed in compliance with the International 10-20 System nomenclature. The increase or decrease in Beta wave EEG recordings of the participants are recorded in eyes closed for 1 min

    Baseline, 7 days, 14 days

  • Change from baseline Theta waves by Non-invasive electroencephalogram (EEG)

    The 32- channel electrodes were placed in compliance with the International 10-20 System nomenclature. The increase or decrease in Theta wave EEG recordings of the participants are recorded in eyes closed for 1 min

    Baseline, 7 days, 14 days

  • Change from baseline hair cortisol level by hair cortisol analysis

    Hair samples will be collected from the participants. Scissors and hair clips will be used to collect hair samples closed to the scalp surface. Each hair sample will be stored in an envelope and labelled with a unique identification code according to the protocol provided by the laboratory appointed. Hair cortisol will be weighted, disinfected and pulverized into fine hair powder. Extraction methods will be applied to the samples by incubation and extraction solvent. The concentration will be measured using a commercially available ELISA kit

    Baseline, 14 days

  • Change from baseline tidal volume by digital spirometer.

    An electronic digital spirometer will be used to measure tidal volume. The participant will need to breathe out through a one-way valve disposable mouthpiece attached to the spirometer.

    Baseline, 7 days, 14 days

  • Change from baseline heart rate variability (HRV) by mobile HRV measurement software

    A mobile HRV measurement software will be applied to measure the HRV of each participant. HRV Changes will be taken after the intervention for 14 days continuously. Change = (Day 14 - baseline, Day 7 - baseline, progressive changes (Day 1 - 14))

    Baseline, Day 1 to day 14

  • Change from baseline by Rosenberg's Self-Esteem Scale

    Rosenberg's Self-esteem scale is a ten-item scale designed to measure one's positive and negative values towards themselves. In other words, it is used to measure individual self-esteem. All answers are in 4-Likert Scales format from 1 (strongly disagree) to 4 (strongly agree). Higher scores indicate higher self-esteem.

    Baseline, 14 days

Secondary Outcomes (1)

  • Change in Go/no-go task performance assessed by the Auditory Go/no-go task

    Baseline, 14 days

Study Arms (2)

Control Group

NO INTERVENTION

Participants (healthy or physically disabled) in the control group do not require to perform audio-guided deep breathing for 14 days continuously

Experimental Group with Audio-guided deep breathing

EXPERIMENTAL

Participants (healthy or physically disabled) in the interventional group need to perform 5 mins audio-guided deep breathing with 6 deep breaths per minute for 14 days continuously

Other: Audio-guided deep breathing

Interventions

2 weeks of audio-guided deep breathing for participants (healthy and physically disabled)

Experimental Group with Audio-guided deep breathing

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Visual Acuity in the better-seeing eye worse than 6/12, according to the criteria of the World Health Organization (for visually impaired only).
  • hair length of at least 1 cm long
  • have consistent internet and computer/laptop/mobile phone access

You may not qualify if:

  • those who are unable to take deep breathing for 5 minutes or more
  • having taken or on drug prescription and medication
  • those who with a medical condition for the past two weeks other than visual impairment
  • other long-term diseases or medical condition impacting physical disability
  • those who do smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tunku Abdul Rahman University

Cheras, Kajang, Selangor, 43000, Malaysia

Location

MeSH Terms

Conditions

Stress, PsychologicalVision Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Poh Foong Lee, PhD

CONTACT

Soo Keng Cheong, MBBS,MRCP

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants do not know which study group they are in.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: The crossover study design is implemented whereby healthy participants are assigned to the control group whereas visually impaired participants are assigned to the intervention group initially. After 14 days, the same participants cross over from the first session to the second session during the experiment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 24, 2022

First Posted

May 27, 2022

Study Start

August 1, 2022

Primary Completion

August 1, 2023

Study Completion

September 1, 2023

Last Updated

June 6, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Based on informed consent, participants data not shared

Locations